Switch to:
More From Other Websites
Achillion Begins Study on First Complement Factor D Inhibitor Feb 12 2016
6:06 am Achillion Pharma initiates phase 1 study of ACH-4471, first orally-administered small... Feb 11 2016
Achillion Initiates Phase 1 Study of ACH-4471, First Orally-Administered Small Molecule Complement... Feb 11 2016
Early Briefing on Biotechnology Stocks -- Achillion Pharma, CTI BioPharma, Inovio Pharma, and Keryx... Feb 10 2016
Achillion to Present at the Leerink Partners 5th Annual Global Healthcare Conference Feb 08 2016
Achillion Announces Appointments of Martha Manning as General Counsel and Amy Jennings as Head of... Feb 03 2016
Achillion Pharma downgraded by Leerink Partners Jan 29 2016
Zacks.com featured expert Kevin Matras highlights: Achillion Pharmaceuticals, Opko Health, Global... Jan 27 2016
A Company's First Profit Can Mean Big Profits to Investors Jan 26 2016
Bulls are playing for Achillion rebound Jan 15 2016
Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : January 8,... Jan 08 2016
Achillion Appoints Dr. Joel Barrish as Chief Scientific Officer Jan 04 2016
Achillion Appoints Dr. Joel Barrish as Chief Scientific Officer Jan 04 2016
4 stocks to watch Dec 31 2015
Achillion (ACHN): Moving Average Crossover Alert Dec 31 2015
Unusual activity in AAL, ACHN Dec 30 2015
Bristol-Myers Inks Deal to Sell HIV Pipeline to ViiV Healthcare Dec 21 2015
Strength Seen in Sequenom (SQNM): Stock Jumps 5% in Session Dec 21 2015
Today's Market Driven by Key Factors -- Research on Tumi Holdings, Meritor, Achillion... Dec 21 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK